Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.42.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.51.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.526 (Iota)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621 (Mu)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.9.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.47 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.17 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.126 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.48 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.116.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.52 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.13 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.35 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used